Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
42,429,433
-
Share change
-
-14,058
-
Total reported value
-
$2,792,382,193
-
Put/Call ratio
-
72%
-
Price per share
-
$65.83
-
Number of holders
-
269
-
Value change
-
+$14,853,355
-
Number of buys
-
122
-
Number of sells
-
129
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2018
As of 30 Sep 2018,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,429,433 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, Invesco Ltd., RICE HALL JAMES & ASSOCIATES, LLC, SNYDER CAPITAL MANAGEMENT L P, and Standard Life Aberdeen plc.
This page lists
269
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.